Skip to Content


In the US, Gatifloxacin (gatifloxacin ophthalmic) is a member of the drug class quinolones and is used to treat Anthrax, Anthrax Prophylaxis, Bladder Infection, Bronchitis, Gonococcal Infection - Uncomplicated, Kidney Infections, Otitis Media, Pneumonia, Sinusitis, Skin or Soft Tissue Infection, Tuberculosis - Active and Urinary Tract Infection.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Fluoroquinolone (gyrase inhibitor)

Chemical Name

(±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-metoxy-7-(3-metyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (WHO)

Foreign Names

  • Gatifloxacinum (Latin)
  • Gatifloxacin (German)
  • Gatifloxacine (French)
  • Gatifloxacino (Spanish)

Generic Names

  • CG 5501 (IS)
  • PD 135432 (IS)
  • UNII-81485Y3A9A (IS)
  • Gatifloxacin (OS: USAN)
  • Gatifloxacin Hydrate (OS: JAN)
  • AM-1155 (IS)
  • BMS-206584-01 (IS)
  • UNII-L4618BD7KJ (IS)

Brand Names


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.